| Description | Selicrelumab, an agonist CD40 antibody, modifies the tumor microenvironment and is utilized in pancreatic cancer research and neoadjuvant studies [1]. |
| molecular weight | N/A |
| CAS | 1622140-49-1 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years |